Noori Torabi is a litigation associate in the firm’s San Francisco office. She focuses her practice on intellectual property law with an emphasis on patent litigation, inter partes review proceedings, and IP risk management and counseling in biotechnology, pharmaceuticals, and medical devices industries.
Noori has experience in all stages of district court litigation including trial. As a member of multiple trial teams, Noori plays a key role in all stages of litigation, from developing case strategies, constructing invalidity and non-infringement defenses, conducting discovery including taking and defending depositions, and drafting dispositive motions, to preparing trial witnesses. Coupled with her extensive knowledge on patent law, Noori’s technical background and her PhD in molecular biology assist her ability to consult and defend biotech and generic pharmaceutical companies in matters concerning an array of scientific issues.
In addition to her trial work, Noori advises clients on patent validity and infringement, provides freedom-to-operate analyses, and conducts due diligence investigations, and provides strategic advice to clients in accordance with business objectives
While receiving her Ph.D. in Molecular Biology from Princeton University, Noori investigated the genetic basis of complex hereditary traits in yeast. She designed and performed various experimental and computational techniques, including high throughput phenotyping and genotyping of extremely large numbers of progeny from a cross between two yeast strains. Noori published four peer-reviewed articles in Nature and PLoS Genetics.
Noori is actively involved in pro bono work. In particular, she has worked on cases involving voting rights, immigration and education advocacy. She also regularly volunteers to help immigrants apply for asylum or citizenship.
Honors and Awards
Noori was named to Best Lawyers: Ones to Watch for Intellectual Property Law 2021 and 2022.
Noori is actively involved in pro bono work. In particular, she has worked on cases involving voting rights, immigration and education advocacy. She also regularly volunteers to help legal permanent residents apply for citizenship.
Noori received her B.S. and M.S. in Biotechnology from the University of Tehran in 2007, where she graduated first in her class. Noori received her Ph.D. in Molecular Biology from Princeton University in 2012, and received her J.D., cum laude, from New York University School of Law in 2015, where she was a member of the NYU Law Intellectual Property and Entertainment Law Society and competition advocacy editor for the NYU Law Moot Court Board.
- K. Vidal, M. Rueckheim, N. Torabi; “Silicon Valley”; Inside Counsel (2017).
- I.M. Ehrenreich, J.S. Bloom, N. Torabi, X. Wang, Y. Jia, and L. Kruglyak; Genetic architecture of highly complex chemical resistance traits across four yeast strains; PLoS Genetics e1002570 (2012).
- N. Torabi, and L. Kruglyak; Genetic Basis of Hidden Phenotypic Variation Revealed by Increased Translational Readthrough in Yeast; PLoS Genetics 8(3) e1002546 (2012).
- N. Torabi, and L. Kruglyak; Variants in SUP45 and TRM10 underlie natural variation in translation termination efficiency inS. cerevisiae. PLoS Genetics 7(7): e1002211 (2011).
- I.M. Ehrenreich, N. Torabi, Y. Jia, J. Kent, S. Martis, J.A. Shapiro, D. Gresham, A.A. Caudy, and L. Kruglyak; Dissection of genetically complex traits with extremely large pools of yeast segregants. Nature (2010).
Accolade 08/19/21Winston & Strawn Attorneys Recognized in Best Lawyers: Ones to Watch in America 2022
Accolade 07/01/21Winston Women Recognized in the 2021 Women in the Law edition of Best Lawyers
Accolade 08/20/20Winston & Strawn Attorneys Recognized in Best Lawyers: Ones to Watch 2021
Webinar 05/29/20Judicial Panel: PTAB’s LEAP Initiative for NextGen Lawyers
New Development 01/22/19Patent Mediation Guide
Newsletter 11/01/18Pro Bono Reporter – Fall 2018
Speaking Engagement 07/21/17Noori Torabi Discusses Recent Developments in Patent Litigation at SVAGC Luncheon
Press Release 06/13/17Five Attorneys Join Winston & Strawn in Silicon Valley
Article 06/12/17Silicon Valley
Blogs & Podcasts
02/24/22Explosive Punitive Damages in California Employment Cases and Why They Matter
11/12/21Functional Genus Claims Directed to Chimeric Antigen Receptors on T-Cells (CAR-T) Were Invalid for Lack of Written Description
10/18/21Chief Scientific Officer’s Contradictory Statements to the FDA and the Patent Office Rendered the Patent Covering Epinephrine Formulations Unenforceable
08/30/21The Language “Shall Be the Property Of” Is a Promise of Future Assignment—Not a Present Automatic Transfer of Intellectual Property Rights
02/10/21Anticipation Finding Based on PTAB’s Claim Interpretation Deprived the Patentee of Due Notice
08/24/20Contracting Away Rights to Use a Mark Does Not Preclude a Petitioner From Challenging the Mark Before the Trademark Trial and Appeal Board
04/17/20Intrinsic Evidence of Statements in Patent Specification May Be Sufficient to Determine Patentability at the Rule 12(b)(6) Stage Under Alice Step One Without Consulting Prior Art
06/21/19A Single Prior Art Reference Can Claims Obvious When Construed Under the Broadest Reasonable Interpretation